Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/STEPS_trial> ?p ?o }
Showing triples 1 to 32 of
32
with 100 triples per page.
- STEPS_trial abstract "The STEPS trial (an acronym for Study of Neurontin: Titrate to Efficacy, Profile of Safety) was a clinical trial sponsored by Parke-Davis (now Pfizer) to evaluate the anticonvulsant Neurontin. It is notable for being a seeding trial to promote that drug and for contributing to the drug companies loss in the court case Franklin v. Parke-Davis.Detailed documents were released due to litigation against Parke-Davis and reviewed by several researchers in a 2011 Annals of Internal Medicine article. The STEPS trial was presented as a phase IV clinical trial with the stated objective to \"study efficacy, safety, tolerability, and quality of life among gabapentin users\", however the trial was actually completely uncontrolled and unblinded and the scientific validity of the trial was considered dubious by independent external sources. Documents also revealed that the trial recruited 772 physician investigators, many with very limited research experience, provided inadequate training for investigators, and that company sales representatives were \"directly involved in collecting and recording individual subject trial data\".The STEPS study has been considered as an example of pharmaceutical marketing merging with research.".
- STEPS_trial wikiPageID "46617995".
- STEPS_trial wikiPageLength "4013".
- STEPS_trial wikiPageOutDegree "14".
- STEPS_trial wikiPageRevisionID "700641499".
- STEPS_trial wikiPageWikiLink Anticonvulsant.
- STEPS_trial wikiPageWikiLink Blind_experiment.
- STEPS_trial wikiPageWikiLink Category:Clinical_trials.
- STEPS_trial wikiPageWikiLink Category:Pfizer.
- STEPS_trial wikiPageWikiLink Clinical_trial.
- STEPS_trial wikiPageWikiLink Franklin_v._Parke-Davis.
- STEPS_trial wikiPageWikiLink Gabapentin.
- STEPS_trial wikiPageWikiLink Lawsuit.
- STEPS_trial wikiPageWikiLink Parke-Davis.
- STEPS_trial wikiPageWikiLink Pfizer.
- STEPS_trial wikiPageWikiLink Pharmaceutical_marketing.
- STEPS_trial wikiPageWikiLink Scientific_control.
- STEPS_trial wikiPageWikiLink Seeding_trial.
- STEPS_trial wikiPageWikiLinkText "STEPS trial".
- STEPS_trial wikiPageUsesTemplate Template:Cite_journal.
- STEPS_trial wikiPageUsesTemplate Template:Reflist.
- STEPS_trial subject Category:Clinical_trials.
- STEPS_trial subject Category:Pfizer.
- STEPS_trial hypernym Trial.
- STEPS_trial type CyclingRace.
- STEPS_trial comment "The STEPS trial (an acronym for Study of Neurontin: Titrate to Efficacy, Profile of Safety) was a clinical trial sponsored by Parke-Davis (now Pfizer) to evaluate the anticonvulsant Neurontin. It is notable for being a seeding trial to promote that drug and for contributing to the drug companies loss in the court case Franklin v. Parke-Davis.Detailed documents were released due to litigation against Parke-Davis and reviewed by several researchers in a 2011 Annals of Internal Medicine article.".
- STEPS_trial label "STEPS trial".
- STEPS_trial sameAs Q20539242.
- STEPS_trial sameAs m.0136zv9c.
- STEPS_trial sameAs Q20539242.
- STEPS_trial wasDerivedFrom STEPS_trial?oldid=700641499.
- STEPS_trial isPrimaryTopicOf STEPS_trial.